WHO temporarily halts studies of hydroxychloroquine in its Solidarity Trial
The World Health Organization said it has halted studies of hydroxychloroquine in its Solidarity Trial after The Lancet published a piece that said a higher mortality rate was estimated for critically ill patients who received the drug, when used alone or with a macrolide, reports ET.
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
